key: cord-0328056-6jp5sbd1
authors: Haan, T. J.; Smith, L. K.; DeRonde, S.; House, E.; Zidek, J.; Puhak, D.; Mullen, L.; Redlinger, M.; Parker, J.; Barnes, B. M.; Burkhead, J. L.; Knall, C.; Bortz, E.; Chen, J.; Drown, D. M.
title: A repeat pattern of founder events for SARS-CoV-2 variants in Alaska
date: 2022-05-26
journal: nan
DOI: 10.1101/2022.05.25.22275610
sha: 69ec1e14767db7c1730b4f501269436a5a8bc2b2
doc_id: 328056
cord_uid: 6jp5sbd1

Alaska is a unique US state because of its large size, geographically disparate population density, and physical distance from the contiguous United States. Here, we describe a pattern of SARS-CoV-2 variant emergence across Alaska reflective of these differences. Using genomic data, we found that in Alaska the Omicron sublineage BA.2.3 overtook BA.1.1 by the week of 2022-02-27, reaching 48.5% of sequenced cases. On the contrary in the contiguous United States, BA.1.1 dominated cases for longer, eventually being displaced by BA.2 sublineages other than BA.2.3. BA.2.3 only reached a prevalence of 10.9% in the contiguous United States. Using phylogenetics, we found evidence of potential origins of the two major clades of BA.2.3 in Alaska and with logistic regression estimated how it emerged and spread throughout the state. The combined evidence is suggestive of founder events in Alaska and is reflective of how Alaska's unique dynamics influence the emergence of SARS-CoV-2 variants.

Washington. Using data generated through genomic surveillance efforts, we explore the pattern 72 in Omicron sublineages of Alaska similar to that of the founder event that occurred with B.1.1.519 73 in early 2021 (Haan et al., 2022 On April 12th, 2022, we downloaded metadata, including lineage assignment using the 96 same version of Pangolin (v4.0.6) for all sequences available on GISAID and filtered for 97 sequences from the United States of America (USA) collected between 2021-11-28 to 2022-04-98 12. We removed cases from Alaska, Hawaii, and US territories to limit our comparisons to the 99 lower 48 contiguous states. We also analyzed data at a state level for New York, California, and 100

Washington. GISAID metadata was used to calculate the prevalence of variants, which was an 101 approximation based on percent of sequenced cases each day. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2022. ; red arrow highlights when the regression estimated BA.2.3 was at greater than 5% prevalence. 359 360 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Only countries that provide context for Alaska clades and clade origins are included in the 364 visualization. 365 366 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 26, 2022. ; https://doi.org/10.1101/2022.05.25.22275610 doi: medRxiv preprint

Data, disease and diplomacy: GISAID's innovative 261 contribution to global health. Global challenges

Making sense of mutation: what 263 D614G means for the COVID-19 pandemic remains unclear

Founder effect contributes to the unique pattern of SARS-CoV-2 variant B. 1.1. 266 519 emergence in Alaska

Antibody evasion properties of SARS-CoV-2 Omicron 269 sublineages

GISAID's Role in Pandemic Response

New variant of SARS-CoV-2 in UK causes surge of COVID-19

Center for Viral Systems Biology outbreak

Assignment of epidemiological lineages in an emerging pandemic using the 280 pangolin tool

High prevalence of 283 SARS-CoV-2 B. 1.1. 7 (UK variant) and the novel B. 1.525 lineage in Oyo State

A dynamic nomenclature proposal for SARS-CoV-2 lineages to 287 assist genomic epidemiology

The causes and 289 consequences of HIV evolution

Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of 296

SARS-CoV-2 predominantly present in Mexico

On the 299 founder effect in COVID-19 outbreaks: how many infected travelers may have started 300 them all

New waves, new variants, old inequity: a continuing COVID-19 crisis

GISAID: Global initiative on sharing all influenza data-from 305 vision to reality

Occurrence and 308 significance of Omicron BA. 1 infection followed by BA

The biological and clinical significance of emerging SARS

CoV-2 variants

Emergence of a new SARS-CoV-2 variant in 313 the UK

Assessing transmissibility 316 of SARS-CoV-2 lineage B. 1.1. 7 in England

Phylogenetic and phylodynamic approaches to understanding and combating the early 254 SARS-CoV-2 pandemic. Nature Reviews Genetics, 1-16. 255